APO Research
Talk to an analyst

APO RESEARCH · REPORT

Depression Treatment Device

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Depression Treatment Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026194 pages

Choose your research edition.

Industry ResearchDepression Treatment Device Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Depression Treatment Device Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal Depression Treatment Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Depression Treatment Device Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Depression Treatment Device Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Depression Treatment Device market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Depression Treatment Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Depression Treatment Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Depression Treatment Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Depression Treatment Device is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Depression Treatment Device include Alpha-Stim, BrainsWay, Caputron Medical, Electromedical Products International, Inc., Fisher Wallace Laboratories, Flow Neuroscience, Flow Neuroscience AB, Ginger and INNOVATIVE NEUROLOGICAL Devices LLC, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Depression Treatment Device market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Depression Treatment Device and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Depression Treatment Device sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Depression Treatment Device market size, projected growth trends, production technologies, key applications, and end-use industries.

Depression Treatment Device Segment by Company

Alpha-Stim

BrainsWay

Caputron Medical

Electromedical Products International, Inc.

Fisher Wallace Laboratories

Flow Neuroscience

Flow Neuroscience AB

Ginger

INNOVATIVE NEUROLOGICAL Devices LLC

Magnus Medical

Neurolief

Neuronetics

NeuroStar

The Magstim Company Limited

Depression Treatment Device Segment by Type

Transcranial Direct Current Stimulation (tDCS)

Transcranial Random Noise Stimulation (tRNS)

Transcranial Pulsed Current Stimulation (tPCS)

Transcranial Alternating Current Stimulation (tACS)

Electroconvulsive therapy (ECT)

Others

Depression Treatment Device Segment by Application

Hospital

Clinic

Others

Depression Treatment Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Depression Treatment Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Depression Treatment Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Depression Treatment Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Depression Treatment Device market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Depression Treatment Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Depression Treatment Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Depression Treatment Device in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Depression Treatment Device Industry Trends Table 2. Depression Treatment Device Industry Drivers Table 3. Depression Treatment Device Industry Opportunities and Challenges Table 4. Depression Treatment Device Industry Restraints Table 5. Global Depression Treatment Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Depression Treatment Device Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Depression Treatment Device Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Depression Treatment Device Sales Market Share by Manufacturers Table 9. Global Depression Treatment Device Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Depression Treatment Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Depression Treatment Device Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Depression Treatment Device Manufacturers, Product Type & Application Table 13. Global Depression Treatment Device Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Depression Treatment Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Transcranial Direct Current Stimulation (tDCS) Table 17. Major Manufacturers of Transcranial Random Noise Stimulation (tRNS) Table 18. Major Manufacturers of Transcranial Pulsed Current Stimulation (tPCS) Table 19. Major Manufacturers of Transcranial Alternating Current Stimulation (tACS) Table 20. Major Manufacturers of Electroconvulsive therapy (ECT) Table 21. Major Manufacturers of Others Table 22. Global Depression Treatment Device Sales by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Depression Treatment Device Sales by Type (2021-2026) & (k units) Table 24. Global Depression Treatment Device Sales by Type (2027-2032) & (k units) Table 25. Global Depression Treatment Device Sales Market Share by Type (2021-2026) Table 26. Global Depression Treatment Device Sales Market Share by Type (2027-2032) Table 27. Global Depression Treatment Device Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 28. Global Depression Treatment Device Revenue by Type (2021-2026) & (k units) Table 29. Global Depression Treatment Device Revenue by Type (2027-2032) & (k units) Table 30. Global Depression Treatment Device Revenue Market Share by Type (2021-2026) Table 31. Global Depression Treatment Device Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Hospital Table 33. Major Manufacturers of Clinic Table 34. Major Manufacturers of Others Table 35. Global Depression Treatment Device Sales by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Depression Treatment Device Sales by Application (2021-2026) & (k units) Table 37. Global Depression Treatment Device Sales by Application (2027-2032) & (k units) Table 38. Global Depression Treatment Device Sales Market Share by Application (2021-2026) Table 39. Global Depression Treatment Device Sales Market Share by Application (2027-2032) Table 40. Global Depression Treatment Device Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 41. Global Depression Treatment Device Revenue by Application (2021-2026) & (k units) Table 42. Global Depression Treatment Device Revenue by Application (2027-2032) & (k units) Table 43. Global Depression Treatment Device Revenue Market Share by Application (2021-2026) Table 44. Global Depression Treatment Device Revenue Market Share by Application (2027-2032) Table 45. Global Depression Treatment Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Depression Treatment Device Sales by Region (2021-2026) & (k units) Table 47. Global Depression Treatment Device Sales Market Share by Region (2021-2026) Table 48. Global Depression Treatment Device Sales Forecasted by Region (2027-2032) & (k units) Table 49. Global Depression Treatment Device Sales Forecasted Market Share by Region (2027-2032) Table 50. North America Depression Treatment Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 51. North America Depression Treatment Device Sales by Country (2021-2026) & (k units) Table 52. North America Depression Treatment Device Sales by Country (2027-2032) & (k units) Table 53. Europe Depression Treatment Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Europe Depression Treatment Device Sales by Country (2021-2026) & (k units) Table 55. Europe Depression Treatment Device Sales by Country (2027-2032) & (k units) Table 56. Asia Pacific Depression Treatment Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Asia Pacific Depression Treatment Device Sales by Country (2021-2026) & (k units) Table 58. Asia Pacific Depression Treatment Device Sales by Country (2027-2032) & (k units) Table 59. South America, Middle East and Africa Depression Treatment Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 60. South America, Middle East and Africa Depression Treatment Device Sales by Country (2021-2026) & (k units) Table 61. South America, Middle East and Africa Depression Treatment Device Sales by Country (2027-2032) & (k units) Table 62. Global Depression Treatment Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Global Depression Treatment Device Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Depression Treatment Device Revenue by Region (2027-2032) & (US$ Million) Table 65. Global Depression Treatment Device Revenue Market Share by Region (2021-2026) Table 66. Global Depression Treatment Device Revenue Market Share by Region (2027-2032) Table 67. Alpha-Stim Company Information Table 68. Alpha-Stim Business Overview Table 69. Alpha-Stim Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Alpha-Stim Depression Treatment Device Product Portfolio Table 71. Alpha-Stim Recent Development Table 72. BrainsWay Company Information Table 73. BrainsWay Business Overview Table 74. BrainsWay Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. BrainsWay Depression Treatment Device Product Portfolio Table 76. BrainsWay Recent Development Table 77. Caputron Medical Company Information Table 78. Caputron Medical Business Overview Table 79. Caputron Medical Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Caputron Medical Depression Treatment Device Product Portfolio Table 81. Caputron Medical Recent Development Table 82. Electromedical Products International, Inc. Company Information Table 83. Electromedical Products International, Inc. Business Overview Table 84. Electromedical Products International, Inc. Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Electromedical Products International, Inc. Depression Treatment Device Product Portfolio Table 86. Electromedical Products International, Inc. Recent Development Table 87. Fisher Wallace Laboratories Company Information Table 88. Fisher Wallace Laboratories Business Overview Table 89. Fisher Wallace Laboratories Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Fisher Wallace Laboratories Depression Treatment Device Product Portfolio Table 91. Fisher Wallace Laboratories Recent Development Table 92. Flow Neuroscience Company Information Table 93. Flow Neuroscience Business Overview Table 94. Flow Neuroscience Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Flow Neuroscience Depression Treatment Device Product Portfolio Table 96. Flow Neuroscience Recent Development Table 97. Flow Neuroscience AB Company Information Table 98. Flow Neuroscience AB Business Overview Table 99. Flow Neuroscience AB Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Flow Neuroscience AB Depression Treatment Device Product Portfolio Table 101. Flow Neuroscience AB Recent Development Table 102. Ginger Company Information Table 103. Ginger Business Overview Table 104. Ginger Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Ginger Depression Treatment Device Product Portfolio Table 106. Ginger Recent Development Table 107. INNOVATIVE NEUROLOGICAL Devices LLC Company Information Table 108. INNOVATIVE NEUROLOGICAL Devices LLC Business Overview Table 109. INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Product Portfolio Table 111. INNOVATIVE NEUROLOGICAL Devices LLC Recent Development Table 112. Magnus Medical Company Information Table 113. Magnus Medical Business Overview Table 114. Magnus Medical Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Magnus Medical Depression Treatment Device Product Portfolio Table 116. Magnus Medical Recent Development Table 117. Neurolief Company Information Table 118. Neurolief Business Overview Table 119. Neurolief Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Neurolief Depression Treatment Device Product Portfolio Table 121. Neurolief Recent Development Table 122. Neuronetics Company Information Table 123. Neuronetics Business Overview Table 124. Neuronetics Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Neuronetics Depression Treatment Device Product Portfolio Table 126. Neuronetics Recent Development Table 127. NeuroStar Company Information Table 128. NeuroStar Business Overview Table 129. NeuroStar Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. NeuroStar Depression Treatment Device Product Portfolio Table 131. NeuroStar Recent Development Table 132. The Magstim Company Limited Company Information Table 133. The Magstim Company Limited Business Overview Table 134. The Magstim Company Limited Depression Treatment Device Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. The Magstim Company Limited Depression Treatment Device Product Portfolio Table 136. The Magstim Company Limited Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Depression Treatment Device Distributors List Table 140. Depression Treatment Device Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Depression Treatment Device Product Image Figure 2. Global Depression Treatment Device Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Depression Treatment Device Market Size (2021-2032) & (US$ Million) Figure 4. Global Depression Treatment Device Sales (2021-2032) & (k units) Figure 5. Global Depression Treatment Device Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Depression Treatment Device Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Transcranial Direct Current Stimulation (tDCS) Image Figure 9. Transcranial Random Noise Stimulation (tRNS) Image Figure 10. Transcranial Pulsed Current Stimulation (tPCS) Image Figure 11. Transcranial Alternating Current Stimulation (tACS) Image Figure 12. Electroconvulsive therapy (ECT) Image Figure 13. Others Image Figure 14. Global Depression Treatment Device Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Depression Treatment Device Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Depression Treatment Device Sales Market Share by Type (2021-2032) Figure 17. Global Depression Treatment Device Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 18. Global Depression Treatment Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Depression Treatment Device Revenue Market Share by Type (2021-2032) Figure 20. Hospital Image Figure 21. Clinic Image Figure 22. Others Image Figure 23. Global Depression Treatment Device Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Depression Treatment Device Sales Market Share 2021 VS 2025 VS 2032 Figure 25. Global Depression Treatment Device Sales Market Share by Application (2021-2032) Figure 26. Global Depression Treatment Device Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 27. Global Depression Treatment Device Revenue Market Share 2021 VS 2025 VS 2032 Figure 28. Global Depression Treatment Device Revenue Market Share by Application (2021-2032) Figure 29. North America Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 30. North America Depression Treatment Device Sales Market Share by Country (2021-2032) Figure 31. U.S. Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 32. Canada Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 33. Mexico Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 34. Europe Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 35. Europe Depression Treatment Device Sales Market Share by Country (2021-2032) Figure 36. Germany Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 37. France Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 38. U.K. Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 39. Italy Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 40. Netherlands Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 41. Asia Pacific Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 42. Asia Pacific Depression Treatment Device Sales Market Share by Country (2021-2032) Figure 43. China Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 44. Japan Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 45. South Korea Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 46. Southeast Asia Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 47. India Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 48. Australia Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 49. South America, Middle East and Africa Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 50. South America, Middle East and Africa Depression Treatment Device Sales Market Share by Country (2021-2032) Figure 51. Brazil Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 52. South Africa Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 53. Saudi Arabia Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 54. Turkey Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 55. Argentina Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 56. UAE Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 57. Egypt Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 58. Chile Depression Treatment Device Sales and Growth Rate (2021-2032) & (k units) Figure 59. Global Depression Treatment Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Global Depression Treatment Device Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 61. North America Depression Treatment Device Revenue (2021-2032) & (US$ Million) Figure 62. North America Depression Treatment Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Europe Depression Treatment Device Revenue (2021-2032) & (US$ Million) Figure 64. Europe Depression Treatment Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Asia-Pacific Depression Treatment Device Revenue (2021-2032) & (US$ Million) Figure 66. Asia-Pacific Depression Treatment Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. South America, Middle East and Africa Depression Treatment Device Revenue (2021-2032) & (US$ Million) Figure 68. South America, Middle East and Africa Depression Treatment Device Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 69. Depression Treatment Device Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Depression Treatment Device Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Transcranial Direct Current Stimulation (tDCS)
  • Transcranial Random Noise Stimulation (tRNS)
  • Transcranial Pulsed Current Stimulation (tPCS)
  • Transcranial Alternating Current Stimulation (tACS)
  • Electroconvulsive therapy (ECT)
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Alpha-Stim
  • BrainsWay
  • Caputron Medical
  • Electromedical Products International, Inc.
  • Fisher Wallace Laboratories
  • Flow Neuroscience
  • Flow Neuroscience AB
  • Ginger
  • INNOVATIVE NEUROLOGICAL Devices LLC
  • Magnus Medical
  • Neurolief
  • Neuronetics
  • NeuroStar
  • The Magstim Company Limited

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Depression Treatment Device Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Depression Treatment Device Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Depression Treatment Device Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Depression Treatment Device Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Depression Treatment Device Market Dynamics
  1. 2.1 Depression Treatment Device Industry Trends
  2. 2.2 Depression Treatment Device Industry Drivers
  3. 2.3 Depression Treatment Device Industry Opportunities and Challenges
  4. 2.4 Depression Treatment Device Industry Restraints
3 Depression Treatment Device Market by Manufacturers
  1. 3.1 Global Depression Treatment Device Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Depression Treatment Device Sales by Manufacturers (2021-2026)
  3. 3.3 Global Depression Treatment Device Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Depression Treatment Device Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Depression Treatment Device Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Depression Treatment Device Manufacturers, Product Type & Application
  7. 3.7 Global Depression Treatment Device Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Depression Treatment Device Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Depression Treatment Device Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Depression Treatment Device Tier 1, Tier 2, and Tier 3
4 Depression Treatment Device Market by Type
  1. 4.1 Depression Treatment Device Type Introduction
  2. 4.1.1 Transcranial Direct Current Stimulation (tDCS)
  3. 4.1.2 Transcranial Random Noise Stimulation (tRNS)
  4. 4.1.3 Transcranial Pulsed Current Stimulation (tPCS)
  5. 4.1.4 Transcranial Alternating Current Stimulation (tACS)
  6. 4.1.5 Electroconvulsive therapy (ECT)
  7. 4.1.6 Others
  8. 4.2 Global Depression Treatment Device Sales by Type
  9. 4.2.1 Global Depression Treatment Device Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Depression Treatment Device Sales by Type (2021-2032)
  11. 4.2.3 Global Depression Treatment Device Sales Market Share by Type (2021-2032)
  12. 4.3 Global Depression Treatment Device Revenue by Type
  13. 4.3.1 Global Depression Treatment Device Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Depression Treatment Device Revenue by Type (2021-2032)
  15. 4.3.3 Global Depression Treatment Device Revenue Market Share by Type (2021-2032)
5 Depression Treatment Device Market by Application
  1. 5.1 Depression Treatment Device Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Depression Treatment Device Sales by Application
  6. 5.2.1 Global Depression Treatment Device Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Depression Treatment Device Sales by Application (2021-2032)
  8. 5.2.3 Global Depression Treatment Device Sales Market Share by Application (2021-2032)
  9. 5.3 Global Depression Treatment Device Revenue by Application
  10. 5.3.1 Global Depression Treatment Device Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Depression Treatment Device Revenue by Application (2021-2032)
  12. 5.3.3 Global Depression Treatment Device Revenue Market Share by Application (2021-2032)
6 Global Depression Treatment Device Sales by Region
  1. 6.1 Global Depression Treatment Device Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Depression Treatment Device Sales by Region (2021-2032)
  3. 6.2.1 Global Depression Treatment Device Sales by Region (2021-2026)
  4. 6.2.2 Global Depression Treatment Device Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Depression Treatment Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Depression Treatment Device Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Depression Treatment Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Depression Treatment Device Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Depression Treatment Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Depression Treatment Device Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Depression Treatment Device Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Depression Treatment Device Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Depression Treatment Device Revenue by Region
  1. 7.1 Global Depression Treatment Device Revenue by Region
  2. 7.1.1 Global Depression Treatment Device Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Depression Treatment Device Revenue by Region (2021-2026)
  4. 7.1.3 Global Depression Treatment Device Revenue by Region (2027-2032)
  5. 7.1.4 Global Depression Treatment Device Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Depression Treatment Device Revenue (2021-2032)
  8. 7.2.2 North America Depression Treatment Device Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Depression Treatment Device Revenue (2021-2032)
  11. 7.3.2 Europe Depression Treatment Device Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Depression Treatment Device Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Depression Treatment Device Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Depression Treatment Device Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Depression Treatment Device Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alpha-Stim
  2. 8.1.1 Alpha-Stim Company Information
  3. 8.1.2 Alpha-Stim Business Overview
  4. 8.1.3 Alpha-Stim Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alpha-Stim Depression Treatment Device Product Portfolio
  6. 8.1.5 Alpha-Stim Recent Developments
  7. 8.2 BrainsWay
  8. 8.2.1 BrainsWay Company Information
  9. 8.2.2 BrainsWay Business Overview
  10. 8.2.3 BrainsWay Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 BrainsWay Depression Treatment Device Product Portfolio
  12. 8.2.5 BrainsWay Recent Developments
  13. 8.3 Caputron Medical
  14. 8.3.1 Caputron Medical Company Information
  15. 8.3.2 Caputron Medical Business Overview
  16. 8.3.3 Caputron Medical Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Caputron Medical Depression Treatment Device Product Portfolio
  18. 8.3.5 Caputron Medical Recent Developments
  19. 8.4 Electromedical Products International, Inc.
  20. 8.4.1 Electromedical Products International, Inc. Company Information
  21. 8.4.2 Electromedical Products International, Inc. Business Overview
  22. 8.4.3 Electromedical Products International, Inc. Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Electromedical Products International, Inc. Depression Treatment Device Product Portfolio
  24. 8.4.5 Electromedical Products International, Inc. Recent Developments
  25. 8.5 Fisher Wallace Laboratories
  26. 8.5.1 Fisher Wallace Laboratories Company Information
  27. 8.5.2 Fisher Wallace Laboratories Business Overview
  28. 8.5.3 Fisher Wallace Laboratories Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Fisher Wallace Laboratories Depression Treatment Device Product Portfolio
  30. 8.5.5 Fisher Wallace Laboratories Recent Developments
  31. 8.6 Flow Neuroscience
  32. 8.6.1 Flow Neuroscience Company Information
  33. 8.6.2 Flow Neuroscience Business Overview
  34. 8.6.3 Flow Neuroscience Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Flow Neuroscience Depression Treatment Device Product Portfolio
  36. 8.6.5 Flow Neuroscience Recent Developments
  37. 8.7 Flow Neuroscience AB
  38. 8.7.1 Flow Neuroscience AB Company Information
  39. 8.7.2 Flow Neuroscience AB Business Overview
  40. 8.7.3 Flow Neuroscience AB Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Flow Neuroscience AB Depression Treatment Device Product Portfolio
  42. 8.7.5 Flow Neuroscience AB Recent Developments
  43. 8.8 Ginger
  44. 8.8.1 Ginger Company Information
  45. 8.8.2 Ginger Business Overview
  46. 8.8.3 Ginger Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ginger Depression Treatment Device Product Portfolio
  48. 8.8.5 Ginger Recent Developments
  49. 8.9 INNOVATIVE NEUROLOGICAL Devices LLC
  50. 8.9.1 INNOVATIVE NEUROLOGICAL Devices LLC Company Information
  51. 8.9.2 INNOVATIVE NEUROLOGICAL Devices LLC Business Overview
  52. 8.9.3 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 INNOVATIVE NEUROLOGICAL Devices LLC Depression Treatment Device Product Portfolio
  54. 8.9.5 INNOVATIVE NEUROLOGICAL Devices LLC Recent Developments
  55. 8.10 Magnus Medical
  56. 8.10.1 Magnus Medical Company Information
  57. 8.10.2 Magnus Medical Business Overview
  58. 8.10.3 Magnus Medical Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Magnus Medical Depression Treatment Device Product Portfolio
  60. 8.10.5 Magnus Medical Recent Developments
  61. 8.11 Neurolief
  62. 8.11.1 Neurolief Company Information
  63. 8.11.2 Neurolief Business Overview
  64. 8.11.3 Neurolief Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Neurolief Depression Treatment Device Product Portfolio
  66. 8.11.5 Neurolief Recent Developments
  67. 8.12 Neuronetics
  68. 8.12.1 Neuronetics Company Information
  69. 8.12.2 Neuronetics Business Overview
  70. 8.12.3 Neuronetics Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Neuronetics Depression Treatment Device Product Portfolio
  72. 8.12.5 Neuronetics Recent Developments
  73. 8.13 NeuroStar
  74. 8.13.1 NeuroStar Company Information
  75. 8.13.2 NeuroStar Business Overview
  76. 8.13.3 NeuroStar Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 NeuroStar Depression Treatment Device Product Portfolio
  78. 8.13.5 NeuroStar Recent Developments
  79. 8.14 The Magstim Company Limited
  80. 8.14.1 The Magstim Company Limited Company Information
  81. 8.14.2 The Magstim Company Limited Business Overview
  82. 8.14.3 The Magstim Company Limited Depression Treatment Device Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 The Magstim Company Limited Depression Treatment Device Product Portfolio
  84. 8.14.5 The Magstim Company Limited Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Depression Treatment Device Value Chain Analysis
  2. 9.1.1 Depression Treatment Device Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Depression Treatment Device Production Mode & Process
  6. 9.2 Depression Treatment Device Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Depression Treatment Device Distributors
  9. 9.2.3 Depression Treatment Device Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst